|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 301 for Nras

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.039s

Categories

Category: Publication
« show all
Type Details Score
Publication
2835730 | J:9173
First Author: Chang HY
Year: 1987
Journal: Oncogene Res
Title: Mouse N-ras genes: organization of the functional locus and of a truncated cDNA-like pseudogene.
Volume: 1
Issue: 2
Pages: 129-36
•
•
•
•
•
Publication
25252692 | J:220627
First Author: Burd CE
Year: 2014
Journal: Cancer Discov
Title: Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.
Volume: 4
Issue: 12
Pages: 1418-29
•
•
•
•
•
Publication
16369533 | J:106133
First Author: Takahashi C
Year: 2006
Journal: Nat Genet
Title: Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor.
Volume: 38
Issue: 1
Pages: 118-23
•
•
•
•
•
Publication
35672316 | J:325350
First Author: Murphy BM
Year: 2022
Journal: Nat Commun
Title: Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation.
Volume: 13
Issue: 1
Pages: 3153
•
•
•
•
•
Publication
22983396 | J:238049
First Author: Kwong LN
Year: 2012
Journal: Nat Med
Title: Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma.
Volume: 18
Issue: 10
Pages: 1503-10
•
•
•
•
•
Publication
15831708 | J:101142
First Author: Wiesner SM
Year: 2005
Journal: Blood
Title: Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse.
Volume: 106
Issue: 3
Pages: 1054-62
•
•
•
•
•
Publication
27109513 | J:234854
First Author: Kong G
Year: 2016
Journal: Leukemia
Title: The ability of endogenous Nras oncogenes to initiate leukemia is codon-dependent.
Volume: 30
Issue: 9
Pages: 1935-8
•
•
•
•
•
Publication
22876308 | J:189834
First Author: Lassen LB
Year: 2012
Journal: PLoS One
Title: Nras overexpression results in granulocytosis, T-cell expansion and early lethality in mice.
Volume: 7
Issue: 8
Pages: e42216
•
•
•
•
•
Publication
23418499 | J:199340
First Author: Ballarín-González B
Year: 2013
Journal: PLoS One
Title: Deregulated Nras expression in knock-in animals harboring a gammaretroviral long terminal repeat at the Nras/Csde1 locus.
Volume: 8
Issue: 2
Pages: e56029
•
•
•
•
•
Publication
24284627 | J:207827
First Author: Li Q
Year: 2013
Journal: Nature
Title: Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness.
Volume: 504
Issue: 7478
Pages: 143-147
•
•
•
•
•
Publication
25815427 | J:222644
First Author: Pawlikowski JS
Year: 2015
Journal: J Invest Dermatol
Title: Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.
Volume: 135
Issue: 8
Pages: 2093-2101
•
•
•
•
•
Publication
29275866 | J:253744
First Author: Kunimoto H
Year: 2018
Journal: Cancer Cell
Title: Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity.
Volume: 33
Issue: 1
Pages: 44-59.e8
•
•
•
•
•
Publication
21586752 | J:174880
First Author: Wang J
Year: 2011
Journal: Blood
Title: Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner.
Volume: 118
Issue: 2
Pages: 368-79
•
•
•
•
•
Publication
31703632 | J:290465
First Author: Shi X
Year: 2019
Journal: BMC Cancer
Title: Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
Volume: 19
Issue: 1
Pages: 1072
•
•
•
•
•
Publication
37847561 | J:343436
 
First Author: Rajagopalan A
Year: 2023
Journal: J Clin Invest
Title: A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice.
Volume: 133
Issue: 24
•
•
•
•
•
Publication
33512434 | J:307795
First Author: Wen Z
Year: 2021
Journal: Blood
Title: Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors.
Volume: 137
Issue: 23
Pages: 3259-3271
•
•
•
•
•
Publication
23303902 | J:198244
First Author: Pedersen M
Year: 2013
Journal: Cancer Discov
Title: Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes.
Volume: 3
Issue: 4
Pages: 458-469
•
•
•
•
•
Publication
20921338 | J:167384
First Author: Wang J
Year: 2010
Journal: Blood
Title: Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia.
Volume: 116
Issue: 26
Pages: 5991-6002
•
•
•
•
•
Publication
34699595 | J:322740
First Author: You X
Year: 2022
Journal: Blood
Title: Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation.
Volume: 139
Issue: 7
Pages: 1066-1079
•
•
•
•
•
Publication
31685810 | J:293435
First Author: Fuentes-Mateos R
Year: 2019
Journal: Cell Death Dis
Title: Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in mice.
Volume: 10
Issue: 11
Pages: 838
•
•
•
•
•
Publication
3865197 | J:8114
First Author: Guerrero I
Year: 1985
Journal: Proc Natl Acad Sci U S A
Title: Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen.
Volume: 82
Issue: 23
Pages: 7810-4
•
•
•
•
•
Publication
25189354 | J:316236
First Author: Coleman DJ
Year: 2015
Journal: Mol Cancer Res
Title: Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.
Volume: 13
Issue: 1
Pages: 186-96
•
•
•
•
•
Publication
28341702 | J:263734
First Author: Giannou AD
Year: 2017
Journal: EMBO Mol Med
Title: NRAS destines tumor cells to the lungs.
Volume: 9
Issue: 5
Pages: 672-686
•
•
•
•
•
Publication
34948179 | J:316844
 
First Author: Ragab N
Year: 2021
Journal: Int J Mol Sci
Title: Oncogenic NRAS Accelerates Rhabdomyosarcoma Formation When Occurring within a Specific Time Frame during Tumor Development in Mice.
Volume: 22
Issue: 24
•
•
•
•
•
Publication
27055865 | J:232797
First Author: Kong G
Year: 2016
Journal: Leukemia
Title: Loss of wild-type Kras promotes activation of all Ras isoforms in oncogenic Kras-induced leukemogenesis.
Volume: 30
Issue: 7
Pages: 1542-51
•
•
•
•
•
Publication
18952898 | J:144858
First Author: Kim WI
Year: 2009
Journal: Blood
Title: RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.
Volume: 113
Issue: 5
Pages: 1086-96
•
•
•
•
•
Publication
2174525 | J:72258
First Author: Mangues R
Year: 1990
Journal: Oncogene
Title: Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene.
Volume: 5
Issue: 10
Pages: 1491-7
•
•
•
•
•
Publication
1328989 | J:72259
First Author: Mangues R
Year: 1992
Journal: Oncogene
Title: Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice.
Volume: 7
Issue: 10
Pages: 2073-6
•
•
•
•
•
Publication
9515813 | J:46415
First Author: Mangues R
Year: 1998
Journal: Cancer Res
Title: Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.
Volume: 58
Issue: 6
Pages: 1253-9
•
•
•
•
•
Publication
9181520 | J:72132
First Author: Mediavilla MD
Year: 1997
Journal: J Pineal Res
Title: Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene.
Volume: 22
Issue: 2
Pages: 86-94
•
•
•
•
•
Publication
28497782 | J:335349
 
First Author: Dorard C
Year: 2017
Journal: Nat Commun
Title: RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma.
Volume: 8
Pages: 15262
•
•
•
•
•
Publication
30377195 | J:269361
First Author: You X
Year: 2018
Journal: Blood
Title: Unique dependence on Sos1 in Kras G12D -induced leukemogenesis.
Volume: 132
Issue: 24
Pages: 2575-2579
•
•
•
•
•
Publication
33283624 | J:335419
First Author: Assenmacher CA
Year: 2021
Journal: J Histochem Cytochem
Title: Classification and Grading of Melanocytic Lesions in a Mouse Model of NRAS-driven Melanomagenesis.
Volume: 69
Issue: 3
Pages: 203-218
•
•
•
•
•
Publication
22718121 | J:335347
First Author: Li A
Year: 2012
Journal: J Invest Dermatol
Title: Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.
Volume: 132
Issue: 11
Pages: 2610-21
•
•
•
•
•
Publication
23274911 | J:198246
First Author: Wang Y
Year: 2013
Journal: Cancer Discov
Title: Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression.
Volume: 3
Issue: 3
Pages: 294-307
•
•
•
•
•
Publication
23687087 | J:201009
First Author: Wang J
Year: 2013
Journal: Blood
Title: Nras(G12D/+) promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions.
Volume: 121
Issue: 26
Pages: 5203-7
•
•
•
•
•
Publication
28343944 | J:317017
 
First Author: Campagne C
Year: 2017
Journal: Cell Signal
Title: RACK1 cooperates with NRASQ61K to promote melanoma in vivo.
Volume: 36
Pages: 255-266
•
•
•
•
•
Publication
27135738 | J:239472
First Author: Souroullas GP
Year: 2016
Journal: Nat Med
Title: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
Volume: 22
Issue: 6
Pages: 632-40
•
•
•
•
•
Publication
23733505 | J:204263
First Author: Xu J
Year: 2013
Journal: Cancer Discov
Title: Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation.
Volume: 3
Issue: 9
Pages: 993-1001
•
•
•
•
•
Publication
25361812 | J:220778
First Author: Burgess MR
Year: 2014
Journal: Blood
Title: Preclinical efficacy of MEK inhibition in Nras-mutant AML.
Volume: 124
Issue: 26
Pages: 3947-55
•
•
•
•
•
Publication
21163920 | J:169608
First Author: Li Q
Year: 2011
Journal: Blood
Title: Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus.
Volume: 117
Issue: 6
Pages: 2022-32
•
•
•
•
•
Publication
24812670 | J:212912
First Author: Kong G
Year: 2014
Journal: J Clin Invest
Title: Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm.
Volume: 124
Issue: 6
Pages: 2762-73
•
•
•
•
•
Publication
32219446 | J:289386
First Author: Zambetti NA
Year: 2020
Journal: Blood
Title: Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice.
Volume: 135
Issue: 20
Pages: 1772-1782
•
•
•
•
•
Publication
31443434 | J:293518
 
First Author: Dong Y
Year: 2019
Journal: Cells
Title: Synergy of NUP98-HOXA10 Fusion Gene and NrasG12D Mutation Preserves the Stemness of Hematopoietic Stem Cells on Culture Condition.
Volume: 8
Issue: 9
•
•
•
•
•
Publication
32569596 | J:299503
First Author: Rahman H
Year: 2021
Journal: J Invest Dermatol
Title: Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo.
Volume: 141
Issue: 1
Pages: 132-141.e3
•
•
•
•
•
Publication
2676841 | J:10048
First Author: Buchberg AM
Year: 1989
Journal: Genomics
Title: Localization of the murine macrophage colony-stimulating factor gene to chromosome 3 using interspecific backcross analysis.
Volume: 5
Issue: 2
Pages: 363-7
•
•
•
•
•
Publication
18566322 | J:138720
First Author: Slape C
Year: 2008
Journal: Blood
Title: Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.
Volume: 112
Issue: 5
Pages: 2017-9
•
•
•
•
•
Publication
28117393 | J:320537
 
First Author: Newlaczyl AU
Year: 2017
Journal: Sci Rep
Title: Quantification of spatiotemporal patterns of Ras isoform expression during development.
Volume: 7
Pages: 41297
•
•
•
•
•
Publication
18372904 | J:132357
First Author: Haigis KM
Year: 2008
Journal: Nat Genet
Title: Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon.
Volume: 40
Issue: 5
Pages: 600-8
•
•
•
•
•
Publication
11679445 | J:72416
First Author: Lyons PA
Year: 2001
Journal: Diabetes
Title: Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse.
Volume: 50
Issue: 11
Pages: 2633-7
•
•
•
•
•
Publication
35561684 | J:325979
First Author: Choi YS
Year: 2022
Journal: Cell
Title: Topical therapy for regression and melanoma prevention of congenital giant nevi.
Volume: 185
Issue: 12
Pages: 2071-2085.e12
•
•
•
•
•
Publication
27911940 | J:250854
First Author: Weyandt JD
Year: 2016
Journal: PLoS One
Title: Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.
Volume: 11
Issue: 12
Pages: e0167205
•
•
•
•
•
Publication
25801914 | J:224952
First Author: Chang YI
Year: 2015
Journal: Leukemia
Title: Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Volume: 29
Issue: 9
Pages: 1847-56
•
•
•
•
•
Publication
28835438 | J:246313
First Author: Dovey OM
Year: 2017
Journal: Blood
Title: Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
Volume: 130
Issue: 17
Pages: 1911-1922
•
•
•
•
•
Publication
27815262 | J:238921
First Author: Zhang J
Year: 2017
Journal: Blood
Title: p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
Volume: 129
Issue: 3
Pages: 358-370
•
•
•
•
•
Publication
27741509 | J:319205
First Author: Nowacka JD
Year: 2016
Journal: Oncotarget
Title: MEK1 is required for the development of NRAS-driven leukemia.
Volume: 7
Issue: 49
Pages: 80113-80130
•
•
•
•
•
Publication
8001974 | J:20389
First Author: Threadgill DS
Year: 1994
Journal: Genomics
Title: Syntenic assignment of human chromosome 1 homologous loci in the bovine.
Volume: 22
Issue: 3
Pages: 626-30
•
•
•
•
•
Publication
28647344 | J:252204
First Author: van Tuyn J
Year: 2017
Journal: J Invest Dermatol
Title: Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function.
Volume: 137
Issue: 10
Pages: 2197-2207
•
•
•
•
•
Publication
31189531 | J:278958
First Author: Gu Z
Year: 2019
Journal: Cancer Discov
Title: Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation.
Volume: 9
Issue: 9
Pages: 1228-1247
•
•
•
•
•
Publication
17576930 | J:122592
First Author: Ha L
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.
Volume: 104
Issue: 26
Pages: 10968-73
•
•
•
•
•
Publication
35904492 | J:330081
First Author: Chen S
Year: 2022
Journal: Cancer Discov
Title: Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.
Volume: 12
Issue: 10
Pages: 2434-2453
•
•
•
•
•
Publication
22945650 | J:203248
First Author: To MD
Year: 2013
Journal: Oncogene
Title: Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
Volume: 32
Issue: 34
Pages: 4028-33
•
•
•
•
•
Publication
35082403 | J:322607
First Author: Wen Z
Year: 2022
Journal: Leukemia
Title: Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in NrasQ61R/+ mice.
Volume: 36
Issue: 4
Pages: 1167-1170
•
•
•
•
•
Publication
27236105 | J:235072
First Author: Halaban R
Year: 2016
Journal: J Invest Dermatol
Title: RASopathy Gene Mutations in Melanoma.
Volume: 136
Issue: 9
Pages: 1755-9
•
•
•
•
•
Publication
7878045 | J:23318
First Author: Umanoff H
Year: 1995
Journal: Proc Natl Acad Sci U S A
Title: The murine N-ras gene is not essential for growth and development.
Volume: 92
Issue: 5
Pages: 1709-13
•
•
•
•
•
Publication
14633661 | J:89348
First Author: Diaz R
Year: 2004
Journal: Carcinogenesis
Title: Complex effects of Ras proto-oncogenes in tumorigenesis.
Volume: 25
Issue: 4
Pages: 535-9
•
•
•
•
•
Publication
12670913 | J:82648
First Author: Pérez de Castro I
Year: 2003
Journal: Cancer Res
Title: Mice deficient for N-ras: impaired antiviral immune response and T-cell function.
Volume: 63
Issue: 7
Pages: 1615-22
•
•
•
•
•
Publication
34006870 | J:306092
First Author: Carr RM
Year: 2021
Journal: Nat Commun
Title: RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.
Volume: 12
Issue: 1
Pages: 2901
•
•
•
•
•
Publication
34148054 | J:310830
First Author: Abdallah MG
Year: 2021
Journal: Leukemia
Title: RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner.
Volume: 35
Issue: 10
Pages: 2983-2988
•
•
•
•
•
Publication
28191887 | J:256455
First Author: Fenouille N
Year: 2017
Journal: Nat Med
Title: The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia.
Volume: 23
Issue: 3
Pages: 301-313
•
•
•
•
•
Publication
20534588 | J:166193
First Author: Liu J
Year: 2010
Journal: J Biol Chem
Title: MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras.
Volume: 285
Issue: 34
Pages: 26599-607
•
•
•
•
•
Publication
11839824 | J:74606
First Author: Wolfman JC
Year: 2002
Journal: Mol Cell Biol
Title: Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38.
Volume: 22
Issue: 5
Pages: 1589-606
•
•
•
•
•
Publication
6572964 | J:7034
First Author: Shimizu K
Year: 1983
Journal: Proc Natl Acad Sci U S A
Title: Three human transforming genes are related to the viral ras oncogenes.
Volume: 80
Issue: 8
Pages: 2112-6
•
•
•
•
•
Publication
6089108 | J:7564
First Author: Ryan J
Year: 1984
Journal: Nucleic Acids Res
Title: Molecular cloning and chromosome assignment of murine N-ras.
Volume: 12
Issue: 15
Pages: 6063-72
•
•
•
•
•
Publication
6089339 | J:7575
First Author: Guerrero I
Year: 1984
Journal: Science
Title: Isolation, characterization, and chromosome assignment of mouse N-ras gene from carcinogen-induced thymic lymphoma.
Volume: 225
Issue: 4666
Pages: 1041-3
•
•
•
•
•
Publication
1461656 | J:3318
First Author: Cases S
Year: 1992
Journal: Oncogene
Title: Inactivation of the murine N-ras gene by gene targeting.
Volume: 7
Issue: 12
Pages: 2525-8
•
•
•
•
•
Publication
23758196 | J:203490
First Author: Song SP
Year: 2013
Journal: Biochem J
Title: Ras palmitoylation is necessary for N-Ras activation and signal propagation in growth factor signalling.
Volume: 454
Issue: 2
Pages: 323-32
•
•
•
•
•
Publication
2204029 | J:10710
First Author: Jeffers M
Year: 1990
Journal: Nucleic Acids Res
Title: Characterization of unr; a gene closely linked to N-ras.
Volume: 18
Issue: 16
Pages: 4891-9
•
•
•
•
•
Publication
16580637 | J:108249
First Author: Tsukamoto S
Year: 2006
Journal: Biochem Biophys Res Commun
Title: Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.
Volume: 343
Issue: 4
Pages: 1105-12
•
•
•
•
•
Publication
24710274 | J:221628
First Author: Hinman MN
Year: 2014
Journal: Mol Cell Biol
Title: Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons.
Volume: 34
Issue: 12
Pages: 2188-97
•
•
•
•
•
Publication
23776078 | J:202288
First Author: Iborra S
Year: 2013
Journal: J Exp Med
Title: N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation.
Volume: 210
Issue: 7
Pages: 1463-79
•
•
•
•
•
Publication
26972179 | J:238116
First Author: Damnernsawad A
Year: 2016
Journal: Stem Cells
Title: Kras is Required for Adult Hematopoiesis.
Volume: 34
Issue: 7
Pages: 1859-71
•
•
•
•
•
Publication
36596811 | J:340917
First Author: Villatoro A
Year: 2023
Journal: Nat Commun
Title: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation.
Volume: 14
Issue: 1
Pages: 12
•
•
•
•
•
Publication
26493479 | J:231488
First Author: Liu P
Year: 2016
Journal: Leukemia
Title: Palmitoylacyltransferase Zdhhc9 inactivation mitigates leukemogenic potential of oncogenic Nras.
Volume: 30
Issue: 5
Pages: 1225-8
•
•
•
•
•
Publication
33441311 | J:304054
First Author: Ney GM
Year: 2021
Journal: Cancer Res
Title: Oncogenic N-Ras Mitigates Oxidative Stress-Induced Apoptosis of Hematopoietic Stem Cells.
Volume: 81
Issue: 5
Pages: 1240-1251
•
•
•
•
•
Publication
29958106 | J:265661
First Author: Pulikkan JA
Year: 2018
Journal: Cell
Title: CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.
Volume: 174
Issue: 1
Pages: 172-186.e21
•
•
•
•
•
Publication
7688967 | J:21787
First Author: Sutter C
Year: 1993
Journal: Mol Carcinog
Title: ras gene activation and aberrant expression of keratin K13 in ultraviolet B radiation-induced epidermal neoplasias of mouse skin.
Volume: 8
Issue: 1
Pages: 13-9
•
•
•
•
•
Publication
18461565 | J:136199
First Author: Mor A
Year: 2008
Journal: Eur J Immunol
Title: N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.
Volume: 38
Issue: 6
Pages: 1493-502
•
•
•
•
•
Publication
29866713 | J:318890
First Author: Jin X
Year: 2018
Journal: Blood Adv
Title: Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells.
Volume: 2
Issue: 11
Pages: 1259-1271
•
•
•
•
•
Publication
27111337 | J:320230
First Author: Lissanu Deribe Y
Year: 2016
Journal: Small GTPases
Title: Interplay between PREX2 mutations and the PI3K pathway and its effect on epigenetic regulation of gene expression in NRAS-mutant melanoma.
Volume: 7
Issue: 3
Pages: 178-85
•
•
•
•
•
Publication
34732703 | J:314703
First Author: Liu Y
Year: 2021
Journal: Nat Commun
Title: Convergence of oncogenic cooperation at single-cell and single-gene levels drives leukemic transformation.
Volume: 12
Issue: 1
Pages: 6323
•
•
•
•
•
Publication
11238881 | J:67374
First Author: Esteban LM
Year: 2001
Journal: Mol Cell Biol
Title: Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development.
Volume: 21
Issue: 5
Pages: 1444-52
•
•
•
•
•
Publication
24894773 | J:214458
First Author: Xue L
Year: 2014
Journal: Blood
Title: NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis.
Volume: 124
Issue: 3
Pages: 426-36
•
•
•
•
•
Publication
7632727 | J:27714
First Author: López-Fernández LA
Year: 1995
Journal: Biochim Biophys Acta
Title: Different developmental pattern of N-ras and unr gene expression in mouse gametogenic and somatic tissues.
Volume: 1263
Issue: 1
Pages: 10-6
•
•
•
•
•
Publication
9244354 | J:41863
First Author: Ganter B
Year: 1997
Journal: Oncogene
Title: Myb binding sites within the N-ras promoter repress transcription.
Volume: 15
Issue: 2
Pages: 193-202
•
•
•
•
•
Publication
16624289 | J:111361
First Author: Martínez-Salgado C
Year: 2006
Journal: Exp Cell Res
Title: Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis.
Volume: 312
Issue: 11
Pages: 2093-106
•
•
•
•
•
Publication
- | J:81262
First Author: Groner B
Year: 1987
Journal: Trends Genet
Title: Targeted expression of the ras and myc oncogenes in transgenic mice
Volume: 3
Issue: 11
Pages: 306-9
•
•
•
•
•
Publication
10085069 | J:53886
First Author: Kim E
Year: 1999
Journal: J Biol Chem
Title: Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells.
Volume: 274
Issue: 13
Pages: 8383-90
•
•
•
•
•
Publication
25070947 | J:216219
First Author: Anastasaki C
Year: 2014
Journal: Hum Mol Genet
Title: Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.
Volume: 23
Issue: 25
Pages: 6712-21
•
•
•
•
•
Publication
25788415 | J:224229
First Author: Bender RH
Year: 2015
Journal: Stem Cells
Title: Activated k-ras, but not h-ras or N-ras, regulates brain neural stem cell proliferation in a raf/rb-dependent manner.
Volume: 33
Issue: 6
Pages: 1998-2010
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom